blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1758934

EP1758934 - COSPEPTIN, COSMEDIN AND THEIR USES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  22.02.2008
Database last updated on 20.07.2024
Most recent event   Tooltip22.02.2008Application deemed to be withdrawnpublished on 26.03.2008  [2008/13]
Applicant(s)For all designated states
The Board of Trustees of the Leland Stanford Junior University
1705 El Camino Real
Palo Alto, CA 94306-1106 / US
For all designated states
Janssen Pharmaceutica NV
Turnhoutseweg 30
2340 Beerse / BE
[N/P]
Former [2007/10]For all designated states
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
1705 El Camino Real
Palo Alto, CA 94306-1106 / US
For all designated states
JANSSEN PHARMACEUTICA N.V.
Turnhoutseweg 30
2340 Beerse / BE
Inventor(s)01 / HSUEH, Aaron J.W.
SUMC Boswell A344
Stanford, California 94305-5317 / US
02 / HSU, Sheau Yu Teddy
2038 Santa Cruz Avenue
Menlo Park, California 94025 / US
03 / BARRETT, Terrance D.
1960 Misty Circle
Encinitas, California 92024 / US
04 / MORTON, Magda F.
1750 Kettner Boulevard 408
San Diego, California 92101 / US
05 / PRENDERGAST, Clodagh
19 Bentley Road
Prenton, CH43 5RX / GB
06 / SHANKLEY, Nigel P.
449 Marview Lane
Solana Beach, California 92075 / US
07 / AVSIAN-KRETCHMER, Orna
4746 Gertrude Drive
Fremont, California 94536 / US
 [2007/10]
Representative(s)Brasnett, Adrian Hugh, et al
Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
[N/P]
Former [2007/10]Brasnett, Adrian Hugh, et al
Mewburn Ellis LLP York House 23 Kingsway
London WC2B 6HP / GB
Application number, filing date05730461.022.03.2005
[2007/10]
WO2005US09392
Priority number, dateUS20040555818P23.03.2004         Original published format: US 555818 P
[2007/10]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2005094453
Date:13.10.2005
Language:EN
[2005/41]
Type: A2 Application without search report 
No.:EP1758934
Date:07.03.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 13.10.2005 takes the place of the publication of the European patent application.
[2007/10]
Search report(s)International search report - published on:US05.04.2007
ClassificationIPC:A61K8/18, A61Q13/00
[2007/21]
CPC:
C07K14/705 (EP,US); A61P1/00 (EP); A61P1/04 (EP);
A61P1/06 (EP); A61P1/08 (EP); A61P13/02 (EP);
A61P3/00 (EP); A61P3/04 (EP); A61P3/10 (EP);
A61P43/00 (EP); A61P9/10 (EP); A61P9/12 (EP);
A61K38/00 (EP,US) (-)
Former IPC [2007/10]C07K14/705
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/10]
Extension statesAL23.10.2006
BA23.10.2006
HR23.10.2006
LV23.10.2006
MK23.10.2006
YU23.10.2006
TitleGerman:COSPEPTIN, COSMEDIN UND IHRE VERWENDUNGEN[2007/10]
English:COSPEPTIN, COSMEDIN AND THEIR USES[2007/10]
French:LA COSPEPTINE, LA COSMEDINE ET LEURS UTILISATIONS[2007/10]
Entry into regional phase23.10.2006National basic fee paid 
23.10.2006Search fee paid 
23.10.2006Designation fee(s) paid 
23.10.2006Examination fee paid 
Examination procedure23.10.2006Examination requested  [2007/10]
25.10.2006Amendment by applicant (claims and/or description)
01.10.2007Application deemed to be withdrawn, date of legal effect  [2008/13]
12.11.2007Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2008/13]
Fees paidPenalty fee
Additional fee for renewal fee
31.03.200703   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]  - PEETERS T.L., "Potential of Grehlin as a Therapeutic Approach for Gastrointestinal Motility Disorders", CURRENT OPINION IN PHARMACOLOGY, (2006), vol. 6, pages 553 - 558, XP003010061

DOI:   http://dx.doi.org/10.1016/j.coph.2006.08.005
 [A]  - BRUBAKER ET AL., "Glucagon-like Peptides Regulate Cell Proliferation and Apoptosis in the Pancreas Gut, and Central Nervous System", ENDOCRINOLOGY, (2004), vol. 145, no. 6, pages 2653 - 2659, XP002350954

DOI:   http://dx.doi.org/10.1210/en.2004-0015
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.